ContributorsPublishersAdvertisers

Dr. Castaneda Puglianini on Outcomes With Cilta-Cel in Relapsed/Refractory Myeloma

onclive.com
 2021-10-06

Omar Castaneda Puglianini, MD, discusses results from the phase 1b/2 CARTITUDE-1 trial evaluating ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma. Omar Castaneda Puglianini, MD, hematology and medical oncologist at Moffitt Cancer Center, discusses results...

www.onclive.com

Comments / 0

Comments / 0